Association of Delayed Surgery with Oncologic Long-term Outcomes in Patients with Locally Advanced Rectal Cancer Not Responding to Preoperative Chemoradiation
Autor: | Claudio Belluco, Monica Ortenzi, Giulia Capelli, Paola De Nardi, Paolo Delrio, Giuseppe Sammarco, Andrea Muratore, Alessandra Aprile, Daniela Rega, Lucia Puca, Giuseppe Sena, Maurizio Degiuli, Roberto Innocente, Carlo Aschele, Davide Pertile, Gaya Spolverato, Gaetano Gallo, S. Deidda, Ugo Elmore, Roberto Ghiselli, Andrea Vignali, Riccardo Danna, Claudio Coco, Angelo Restivo, Stefano Scabini, Francesco Puccetti, Mario Guerrieri, G. Rizzo, Luigi Zorcolo, Donato Paolo Pafundi, Pietro Conti, Rossella Reddavid, Riccardo Rosati, Marcello Calabrò, Salvatore Pucciarelli, Alessandro Pastorino, M. Zuin |
---|---|
Přispěvatelé: | Deidda, Simona, Elmore, Ugo, Rosati, Riccardo, De Nardi, Paola, Vignali, Andrea, Puccetti, Francesco, Spolverato, Gaya, Capelli, Giulia, Zuin, Matteo, Muratore, Andrea, Danna, Riccardo, Calabrò, Marcello, Guerrieri, Mario, Ortenzi, Monica, Ghiselli, Roberto, Scabini, Stefano, Aprile, Alessandra, Pertile, Davide, Sammarco, Giuseppe, Gallo, Gaetano, Sena, Giuseppe, Coco, Claudio, Rizzo, Gianluca, Pafundi, Donato Paolo, Belluco, Claudio, Innocente, Roberto, Degiuli, Maurizio, Reddavid, Rossella, Puca, Lucia, Delrio, Paolo, Rega, Daniela, Conti, Pietro, Pastorino, Alessandro, Zorcolo, Luigi, Pucciarelli, Salvatore, Aschele, Carlo, Restivo, Angelo |
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
Male
medicine.medical_specialty Colorectal cancer medicine.medical_treatment Locally advanced Preoperative care Disease-Free Survival chemoradiotherapy Time-to-Treatment adjuvant medicine Humans Stage (cooking) Neoadjuvant therapy Aged Neoplasm Staging Retrospective Studies business.industry Rectal Neoplasms Retrospective cohort study Chemoradiotherapy Adjuvant Middle Aged medicine.disease Colorectal surgery Neoadjuvant Therapy Surgery Italy chemoradiotherapy adjuvant disease-free survival neoplasm staging Female business Cohort study |
Popis: | Extending the interval between the end of neoadjuvant chemoradiotherapy (CRT) and surgery may enhance tumor response in patients with locally advanced rectal cancer. However, data on the association of delaying surgery with long-term outcome in patients who had a minor or poor response are lacking.To assess a large series of patients who had minor or no tumor response to CRT and the association of shorter or longer waiting times between CRT and surgery with short- and long-term outcomes.This is a multicenter retrospective cohort study. Data from 1701 consecutive patients with rectal cancer treated in 12 Italian referral centers were analyzed for colorectal surgery between January 2000 and December 2014. Patients with a minor or null tumor response (ypT stage of 2 to 3 or ypN positive) stage greater than 0 to neoadjuvant CRT were selected for the study. The data were analyzed between March and July 2020.Patients who had a minor or null tumor response were divided into 2 groups according to the wait time between neoadjuvant therapy end and surgery. Differences in surgical and oncological outcomes between these 2 groups were explored.The primary outcomes were overall and disease-free survival between the 2 groups.Of a total of 1064 patients, 654 (61.5%) were male, and the median (IQR) age was 64 (55-71) years. A total of 579 patients (54.4%) had a shorter wait time (8 weeks or less) 485 patients (45.6%) had a longer wait time (greater than 8 weeks). A longer waiting time before surgery was associated with worse 5- and 10-year overall survival rates (67.6% [95% CI, 63.1%-71.7%] vs 80.3% [95% CI, 76.5%-83.6%] at 5 years; 40.1% [95% CI, 33.5%-46.5%] vs 57.8% [95% CI, 52.1%-63.0%] at 10 years; P .001). Also, delayed surgery was associated with worse 5- and 10-year disease-free survival (59.6% [95% CI, 54.9%-63.9%] vs 72.0% [95% CI, 67.9%-75.7%] at 5 years; 36.2% [95% CI, 29.9%-42.4%] vs 53.9% [95% CI, 48.5%-59.1%] at 10 years; P .001). At multivariate analysis, a longer waiting time was associated with an augmented risk of death (hazard ratio, 1.84; 95% CI, 1.50-2.26; P .001) and death/recurrence (hazard ratio, 1.69; 95% CI, 1.39-2.04; P .001).In this cohort study, a longer interval before surgery after completing neoadjuvant CRT was associated with worse overall and disease-free survival in tumors with a poor pathological response to preoperative CRT. Based on these findings, patients who do not respond well to CRT should be identified early after the end of CRT and undergo surgery without delay. |
Databáze: | OpenAIRE |
Externí odkaz: |